Literature DB >> 18307003

Giant T4 rectal carcinoma mimicking urinary bladder adenocarcinoma accurately diagnosed by immunohistochemistry and successfully treated with total pelvic exenteration: report of a case.

Koh Miura1, Terutada Kobayashi, Yuji Funayama, Kouhei Fukushima, Hitoshi Ogawa, Atsushi Oyama, Akihiro Itoh, Takuya Moriya, Takayuki Yamada, Tadayuki Okumoto, Chikashi Shibata, Iwao Sasaki.   

Abstract

A 54-year-old man, with the chief complaints of hematuria, pollakisuria, and pneumaturia, was referred to our hospital, with a diagnosis of giant urinary bladder adenocarcinoma with massive invasion to the rectum. On the basis of the radiological diagnosis and findings of hematoxylin and eosin (H&E) of biopsy specimens, it was difficult to conclude whether the adenocarcinoma originated in the bladder or in the rectum. The immunohistochemical staining of the biopsy specimens showed cytokeratin 7 (CK7)(-) and CK20(+), which supported the notion that the adenocarcinoma possibly originated from the rectum. Although the prognosis of T4 bladder adenocarcinomas has been reported to be quite poor in comparison with that of transitional cell carcinomas, the postoperative prognosis of T4 rectal adenocarcinomas has been reported to be more favorable and such tumors are recommended to be surgically resected. Because no distant metastasis was detected, the patient underwent total pelvic exenteration with a reconstruction of the ileal conduit. Although the resected tumor measured 12 cm in diameter with n1 metastasis, the radial margin was cancer-negative, and the tumor was curatively resected. The immunohistochemical diagnosis of the resected tumor showed carcinoembryonic antigen(+), CK7(-), CK20(+), thrombomodulin(-), and uroplakin(-), which supported the rectal origin. At present the patient is undergoing postoperative adjuvant chemotherapy for rectal cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18307003     DOI: 10.1007/s00595-007-3592-7

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  20 in total

1.  Outcome of total pelvic exenteration for primary rectal cancer.

Authors:  Hideyuki Ike; Hiroshi Shimada; Shigeki Yamaguchi; Yasushi Ichikawa; Shouichi Fujii; Shigeo Ohki
Journal:  Dis Colon Rectum       Date:  2003-04       Impact factor: 4.585

Review 2.  Systemic therapy for metastatic colorectal cancer: current options, current evidence.

Authors:  Hanna Kelly; Richard M Goldberg
Journal:  J Clin Oncol       Date:  2005-07-10       Impact factor: 44.544

3.  Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma.

Authors:  H L Wang; D W Lu; L M Yerian; N Alsikafi; G Steinberg; J Hart; X J Yang
Journal:  Am J Surg Pathol       Date:  2001-11       Impact factor: 6.394

4.  Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases.

Authors:  P Chu; E Wu; L M Weiss
Journal:  Mod Pathol       Date:  2000-09       Impact factor: 7.842

5.  Primary adenocarcinoma of bladder.

Authors:  T G Wilson; T R Pritchett; G Lieskovsky; N E Warner; D G Skinner
Journal:  Urology       Date:  1991-09       Impact factor: 2.649

6.  Primary adenocarcinoma of the urinary bladder. A clinicopathologic and prognostic study.

Authors:  C Anderström; S L Johansson; L von Schultz
Journal:  Cancer       Date:  1983-10-01       Impact factor: 6.860

7.  Primary non-urachal adenocarcinoma of the bladder.

Authors:  S A Kramer; J Bredael; B P Croker; D F Paulson; J F Glenn
Journal:  J Urol       Date:  1979-03       Impact factor: 7.450

8.  Aggressive surgical treatment for patients with T4 rectal cancer.

Authors:  Y Moriya; T Akasu; S Fujita; S Yamamoto
Journal:  Colorectal Dis       Date:  2003-09       Impact factor: 3.788

9.  Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas.

Authors:  Douglas C Parker; Andrew L Folpe; Julie Bell; Esther Oliva; Robert H Young; Cynthia Cohen; Mahul B Amin
Journal:  Am J Surg Pathol       Date:  2003-01       Impact factor: 6.394

10.  High expression of human uroplakin Ia in urinary bladder transitional cell carcinoma.

Authors:  Susumu Kageyama; Tatsuhiro Yoshiki; Takahiro Isono; Tsutomu Tanaka; Chol Jang Kim; Takeshi Yuasa; Yusaku Okada
Journal:  Jpn J Cancer Res       Date:  2002-05
View more
  1 in total

Review 1.  Differentiating rectal carcinoma by an immunohistological analysis of carcinomas of pelvic organs based on the NCBI Literature Survey and the Human Protein Atlas database.

Authors:  Koh Miura; Kazuyuki Ishida; Wataru Fujibuchi; Akihiro Ito; Hitoshi Niikura; Hitoshi Ogawa; Iwao Sasaki
Journal:  Surg Today       Date:  2012-03-23       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.